個案總覽

Dr. Stuart Weisman, CEO of ePhysician, creator of a hand-held device for entering prescriptions and capturing changes, wonders whether his marketing strategy is appropriate. Although everyone agrees that the product is excellent, the sales results are meager to date.

Describes Jeff Miller's attempt to implement Geoffrey Moore's crossing the chasm ideas at enterprise software vendor, Documentum.

Spreadsheet supplement for case 502026.

Moonsnail Soapworks is a small manufacturer of natural, handmade soap products. The founder and co-owner of the company wants to address three key issues. First, to decide whether to introduce a new cream and if so, determine the strategy to be used for pricing, distribution and promotion. Second, to determine whether the move to a new location had been beneficial for the company; and third; to decide on the best strategy to improve performance and profitability at one of Canada's largest craft shows. All of these decisions need to consider the company's current financial health and cash position.

In February 2001, the CEO of a new technology start-up had to decide how to present his firm's value proposition to future clients, customers, and business partners. The technology allowed distribution of full-motion video clips of sports highlights to "third generation" (3G) mobile phones. The plan was to target sports enthusiasts initially in Europe along with mobile phone companies, sports leagues, and networks.

In an unprecedented move in mid-1998, Blue Cross of California, a unit of WellPoint Health Networks, Inc., filed a Citizen Petition with the FDA to switch Claritin, manufactured by Schering-Plough, and two other second-generation antihistamines from prescription-only to over-the-counter (OTC) status. Prescription pharmaceuticals like Claritin were covered by insurance programs, whereas OTC drugs were not. In the late 1990s, U.S. spending on prescription pharmaceuticals had increased significantly, in part as a result of direct-to-consumer advertising of prescription drugs, and posed a substantial burden on insurance companies. Blue Cross argued that the switch would make the drugs more widely available to consumers and would benefit consumers because the second-generation antihistamines were non sedating, unlike the 100 antihistamines sold on the OTC market. Manufacturers opposed the switch because it would put the second-generation antihistamines under considerable price pressure and would disrupt their product planning. Moreover, a switch initiated by an insurance company could lead to future petitions for switches of other prescription drugs. Just under three years later, on May 11, 2001, an FDA advisory committee voted overwhelmingly that the three second-generation antihistamines could safely be marketed over the counter. Although the vote was not binding, the FDA usually acted in accord with the judgements of its advisory committees. The pharmaceutical companies strongly objected to the committee's vote and faced the challenge of developing a strategy for dealing with the threat.

The Sony AIBO is the world's first "entertainment" robot. Positioned as a household "companion," the $1,500 AIBO has become a smash hit in Japan, appealing to both the young and the old, including those with little technical expertise. In the United States, the AIBO is in hot demand among "techies" infatuated with high-tech gadgets; however, it has yet to catch on with the mainstream. The task for Takeshi Yazawa, VP and general manager of Sony Entertainment Robot America, is to figure out how to market the AIBO to the American masses. Includes color exhibits.

The A case describes the start of a new business, Telezoo, and the challenges facing a start-up as it attempts to develop a unique place for itself in the marketplace.

The case provides the background for a hands-on data-mining exercise. The purpose of the analysis is to identify high value customers of an online retailer in order to give them VIP treatment. The exercise is described in "Identifying the VIPs at eTOTS" (UV2918).

This case contains the instructions for a hands-on data-mining exercise. The purpose of the exercise is to identify high value customers of an online retailer in order to give them VIP treatment. The exercise uses purchase data for 60,000 customers. The background is described in "Customer Care at eTots.com" (UV2916).

Spreadsheet supplement for UV2916 and UV2918.

Spreadsheet supplement for UV2916 and UV2918.

The purpose of this note is to prepare the student for a series of exercises in making marketing economics calculations. These calculations are not replacements for spreadsheets or more detailed economic calculations such as net present value or return on investment. They are "back of the envelope" estimates that can easily be communicated to others to buttress arguments about what a company should or should not do in a decision situation.

In early 1999, the president of Sony Computer Entertainment, Inc., had to determine the appropriate U.S. launch strategy for the next-generation video game player, Sony PlayStation2. Despite the success of the original PlayStation1, new competitors and an uncertain consumer environment make the launch difficult. A rewritten version of an earlier case.

This case documents how SpaceDisk started out as a provider of free Web-based storage space. When the potential for such subscription and advertising revenues began to look less attractive, and SpaceDisk saw an opportunity in launching a DAP, the company moved rapidly to develop its new service and roll out its infrastructure.

Conventional pricing is being turned on its head. Deciding what prices to charge represents one of the more visible decision variables confronting managers. Prices send clear messages about customer value and company objectives. Yet, pricing has been one of the least emphasized strategic issues. Historically, managers have taken price for granted, thinking its main function was to cover costs and provide a target rate of return. Now, companies are adopting more sophisticated approaches. A strategic perspective on pricing includes price objectives, price strategy, price structure, price levels, and price promotions. E-commerce opens new opportunities for using differentiated pricing all the time, optimizing pricing by creating customer switching barriers, and differentiating by stage. Challenges to management include the development of technology that facilitates customer price searching and customers making rather than taking prices. An integrative framework for analysis combines the dimensions of strategic pricing with market-based versus cost-based, proactive versus reactive, risk-assumptive versus risk-aversive, and flexible versus standardized dimensions.

BootCamp4MBA.COM is an online educational Web site that helps students prepare for an MBA program or undergraduate degree. The president of Strategic Management Science, Incorporated, the owner of BootCamp4MBA.COM, struggles to improve the sales of BootCamp's online business school preparatory courses. A comprehensive marketing plan must be developed and implemented quickly, including appropriate pricing, product offerings and market communications necessary to advertise and sell products and services online.

Centra is a pioneer in software eLearning. It is debating how to modify its go-to-market strategy, adding telesales to improve sales force productivity. At the same time, its market is evolving, and management thinks it may be about to "cross the chasm" in Geoffrey Moore's terminology. Should it "fish where the fish are biting" or should it concentrate on the enterprise customer and exclude small and mid-size corporations? If a shakeout is coming, how can Centra ensure that it either survives or is acquired by one of the survivors?

It is early 2001 and the Medicines Co. just received FDA approval to market Angiomax, a blood thinner to be used during angioplasties and heart procedures. It is intended to be a better alternative to Heparin, an 80-year-old drug that costs less then $10 per dose. The company believes it can sell Angiomax for a much higher price than Heparin--but how much more? Angiomax also represents the first of several drugs being developed under a rather unique business model. The company is in the business of "rescuing" drugs that other companies have given up on--i.e., they purchase or license the rights to drugs that other companies have halted development on, with the intent of completing the development process and bringing the drug to market. With the success of Angiomax, the company feels that this business model has been validated.

The prices we encounter in the course of making a purchase can affect how much we're willing to pay for a given product--even when the goods involved are entirely unrelated.